Grow Therapy Raises $105M in Series C

Grow Therapy has successfully raised $105M in a Series C at a $1.2B valuation led by TCV, Transformation Capital.

Company Overview

Grow Therapy is a HealthTech company headquartered in New York, NY, founded in 2020 with 300+ employees.

Mental health marketplace

Fundraising Details

Amount Raised: $105M
Round Type: Series C
Valuation: $1.2B
Date: 2025-03-01
Investors: TCV, Transformation Capital

About Grow Therapy

Mental health marketplace The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: New York, NY
Founded: 2020
Team Size: 300+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Grow Therapy's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Grow Therapy's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1.2B valuation marks an important milestone for Grow Therapy, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Grow Therapy is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-03-01. For more information about Grow Therapy, visit their headquarters at New York, NY.

Grow Therapy